Discover the complete record of transactions filed by Atlas Venture Fund XI, L.P.. Officer active across 4 companies, notably Day One Biopharmaceuticals, Inc.. In total, 10 disclosures have been recorded. Total volume traded: €3.4m. The latest transaction was disclosed on 30 March 2021 — Acquisition. Regulator: SEC (Form 4). All data is free.
Atlas Venture Fund XI, L.P. serves as a director and insider for several companies, including Day One Biopharmaceuticals, Inc., Dyne Therapeutics, Inc., Xilio Therapeutics, Inc., and Ikena Oncology, Inc.